GB2109684B - Serum thymic factor for use in the treatment of immuno deficiency - Google Patents

Serum thymic factor for use in the treatment of immuno deficiency

Info

Publication number
GB2109684B
GB2109684B GB08227075A GB8227075A GB2109684B GB 2109684 B GB2109684 B GB 2109684B GB 08227075 A GB08227075 A GB 08227075A GB 8227075 A GB8227075 A GB 8227075A GB 2109684 B GB2109684 B GB 2109684B
Authority
GB
United Kingdom
Prior art keywords
treatment
immuno deficiency
thymic factor
serum thymic
serum
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB08227075A
Other languages
English (en)
Other versions
GB2109684A (en
Inventor
Yoshitaka Nagai
Hayao Abe
Masanobu Arita
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsui Pharmaceuticals Inc
Original Assignee
Mitsui Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsui Pharmaceuticals Inc filed Critical Mitsui Pharmaceuticals Inc
Publication of GB2109684A publication Critical patent/GB2109684A/en
Application granted granted Critical
Publication of GB2109684B publication Critical patent/GB2109684B/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
GB08227075A 1981-09-22 1982-09-22 Serum thymic factor for use in the treatment of immuno deficiency Expired GB2109684B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP56148725A JPS5852225A (ja) 1981-09-22 1981-09-22 脱髄疾患治療剤

Publications (2)

Publication Number Publication Date
GB2109684A GB2109684A (en) 1983-06-08
GB2109684B true GB2109684B (en) 1986-05-29

Family

ID=15459209

Family Applications (1)

Application Number Title Priority Date Filing Date
GB08227075A Expired GB2109684B (en) 1981-09-22 1982-09-22 Serum thymic factor for use in the treatment of immuno deficiency

Country Status (5)

Country Link
US (2) US5112810A (enExample)
JP (1) JPS5852225A (enExample)
DE (1) DE3234947A1 (enExample)
FR (1) FR2513125B1 (enExample)
GB (1) GB2109684B (enExample)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5352665A (en) * 1987-11-24 1994-10-04 Mitsui Toatsu Chemicals, Incorporated Method of treating disease caused by the infection of virus
JP2709839B2 (ja) * 1987-12-25 1998-02-04 三井東圧化学株式会社 膵疾患等の予防・治療剤
US5288706A (en) * 1987-12-25 1994-02-22 Mitsui Toatsu Chemicals, Incorporated Medicament for prevention and remedy of diseases of the pancreas and others
JPH01316328A (ja) * 1988-06-15 1989-12-21 Mitsui Toatsu Chem Inc 老化防止、細胞賦活、老人病予防・治療のための薬剤
US6150136A (en) * 1995-11-14 2000-11-21 The Regents Of The University Of California Nucleotide sequence encoding oligodendrocyte-specific protein
US5756300A (en) * 1995-11-14 1998-05-26 Research Genetics, Inc. Oligodendrocyte-specific protein and method for diagnosing and treating disease
FR2741076B1 (fr) * 1995-11-15 1998-01-30 Rech De Pathologie Appliquee S Conjugues peptidiques derives des hormones thymiques, leur utilisation a titre de medicament et compositions les contenant
US6103748A (en) * 1998-06-19 2000-08-15 Bryan; Thomas B. Method of treating an autoimmune disorder
AU2001280199A1 (en) * 2000-08-28 2002-03-13 Akira Awaya Medicinal compositions
US6716434B1 (en) * 2000-09-19 2004-04-06 Daniel R. Ansley Composition and method for immunostimulation in non- mammalian vertebrates
US6719984B1 (en) * 2000-09-19 2004-04-13 Daniel R. Ansley Composition and method for immunomodulation in mammals
US7858602B2 (en) * 2000-10-16 2010-12-28 Rodriguez Victorio C Therapeutic and prophylactic uses of cell specific carbonic anhydrase enzymes in treating aging disorders due to oxidative stress and as growth factors of stem cells
US7658926B2 (en) * 2001-09-14 2010-02-09 Opexa Pharmaceuticals, Inc. Autologous T-cell vaccines materials and methods
FR2830451B1 (fr) * 2001-10-09 2004-04-30 Inst Nat Sante Rech Med Utilisation de peptides analogues de la thymuline(pat)pour la fabrication de medicaments contre la douleur
JP4721626B2 (ja) * 2002-06-24 2011-07-13 昭 粟屋 アレルギー性鼻炎・結膜炎あるいは皮膚アレルギーやアトピー性皮膚炎の予防・治療法
US7695713B2 (en) * 2002-08-08 2010-04-13 Baylor College Of Medicine Isolation and identification of T cells
PT2016414E (pt) * 2006-05-05 2015-11-24 Opexa Therapeutics Vacina de células t
ITRM20060584A1 (it) * 2006-10-27 2008-04-28 Francesco Bistoni Uso della timosina alfa 1 la preparazione di un medicamento per la prevenzione e la cura delle malattie autoimmuni
RU2010146489A (ru) 2008-04-16 2012-05-27 Момента Фармасьютикалз, Инк. (Us) Анализ композиций сополимера аминокислот
FR2930156B1 (fr) 2008-04-21 2011-10-28 Cll Pharma Utilisation du nonapeptide pat dans le traitement des maladies autoimmunes.
MX2011009967A (es) * 2009-03-26 2012-01-25 Ford Henry Health System Composiciones y metodo para mejorar el resultado neurologico despues de daño neural y enfermedad neurodegenerativa.
US9468662B2 (en) 2010-07-12 2016-10-18 Orphit Use of the PAT nonapeptide in the treatment and prevention of neurodegenerative diseases
FR2962335B1 (fr) * 2010-07-12 2013-01-18 Cll Pharma Utilisation du nonapeptide pat dans le traitement et la prevention des maladies neurodegeneratives
WO2013009885A2 (en) 2011-07-11 2013-01-17 Momenta Pharmaceuticals, Inc. Evaluation of copolymer diethylamide
US8575198B1 (en) 2011-09-07 2013-11-05 Momenta Pharmaceuticals, Inc. In-process control for the manufacture of glatiramer acetate
US11382885B2 (en) 2017-06-07 2022-07-12 The Regents Of The University Of California Compositions for treating fungal and bacterial biofilms and methods of using the same
US12226386B2 (en) 2018-12-03 2025-02-18 The Regents Of The University Of California Compositions and methods for treating biofilms
US12109176B1 (en) 2023-04-20 2024-10-08 Thomas Bryan Effect of glycerol on biofilm forming bacteria and fungi that changes the microbes sensitivity to pro and anti-biofilm non-toxic, non-bonded plasma amino acids and amino acid derivatives

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7502830A (nl) * 1974-03-25 1975-09-29 Jean Francois Bach En Dr Jean Werkwijze voor het isoleren van een polypeptide hormoon.
DE2732587A1 (de) * 1976-09-22 1978-03-23 Bach Jean Francois Polypeptid mit thymischer wirksamkeit
FR2365347A2 (fr) * 1976-09-22 1978-04-21 Bach Jean Francois Nouvelle hormone polypeptide possedant une activite thymique et son procede de preparation
CH637111A5 (fr) * 1977-05-25 1983-07-15 Anvar Composes polypeptidiques a activite thymique ou antagoniste et leurs procedes de synthese.
JPS54148722A (en) * 1978-05-12 1979-11-21 Takeda Chem Ind Ltd Nonapeptide and its preparation
JPS5839144B2 (ja) * 1978-05-15 1983-08-27 株式会社トクヤマ 炭酸モノエステルの製造方法
JPS56148725A (en) * 1980-04-18 1981-11-18 Fujitsu Ltd Magnetic head

Also Published As

Publication number Publication date
JPS5852225A (ja) 1983-03-28
GB2109684A (en) 1983-06-08
US5112810A (en) 1992-05-12
FR2513125A1 (fr) 1983-03-25
JPH0371413B2 (enExample) 1991-11-13
DE3234947A1 (de) 1983-04-07
US5464816A (en) 1995-11-07
FR2513125B1 (fr) 1987-07-03

Similar Documents

Publication Publication Date Title
GB2109684B (en) Serum thymic factor for use in the treatment of immuno deficiency
IL78993A0 (en) Antibodies and kit for use in radiotherapy and radioimmunoassay utilizing the same
GB2110100B (en) Mixing components in proportion
EP0119629A3 (en) Use of anti-idiotype antibodies in immunoassay
IL84653A0 (en) Carboxybutenoic acids and processes for the preparation thereof
GB2165331B (en) Improvements in hose for the conveyance of fluids
EP0494705A3 (en) Determination of ions in fluids
DE3370378D1 (en) Biologically active composition and immunoassay using the same
ZA85206B (en) Protein conjugates useful in the treatment of thrombotic disease
DE3380125D1 (en) Assay for the free portion of substances in biological fluids
DE3274017D1 (en) Assay and use
DE3268135D1 (en) Peptide-type substrates useful in the quantitative determination of endotoxin
DE3479671D1 (en) Improvements in or relating to antibody preparations
DE3162108D1 (en) Peptides for use in determining serum thymic factor
DE3370543D1 (en) Process for the determination of interferon and kit for the assay of interferon
GR80009B (en) Novel peptides with immune stimulated action method for the preparation and use thereof
EP0257421A3 (en) Antibodies for use in determining human glycoalbumin
DE3173632D1 (en) Derivatives of iodothyronine compounds and their use in an assay for the free iodothyronine compounds
EP0103139A3 (en) Reagent composition for immunoassay and immunoassay using the same
DE3369386D1 (en) Assay for the free portion of substances in biological fluids
GB2158250B (en) Determining one gas in the presence of another
GB2146028B (en) Spf-100 and process for the preparation thereof
GB2143574B (en) Improvements in deadlocks
DE3369732D1 (en) Method of determination of human urine kallikrein and kit for the same
AU572891B2 (en) Determining the origin of particles in urine

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 19980922